CareTech Human successfully closed their pre-seed bridge round and is entering a new phase of growth for their smart toilet urology monitoring solution. Read more on CareTech Human →
TETmedical appointed diagnostics commercialization executive Arjun Ishwar as chief commercial officer as NSE-FAST advances toward pivotal study.
A peer-reviewed preclinical study found AVA-003 outperformed chlorhexidine against Candida auris on skin, advancing AvantGuard’s development program.
